Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arrhythmogenic right ventricular dysplasia.

G Fontaine1, F Fontaliran, J L Hébert

  • 1Service de Cardiologie, Hôpital Jean Rostand, Ivry sur Seine, France.

Annual Review of Medicine
|March 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When one cannot see the forest for the trees: femoral dP/dt<sub>max</sub>, LVEF and pulse pressure in critically ill patients.

Annals of intensive care·2019
Same author

Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.

Pulmonology·2019
Same author

[Pathophysiology of right ventricular hemodynamics].

Revue des maladies respiratoires·2018
Same author

A portrait of a female body: Rubens and Helena's legs.

Medical humanities·2013
Same author

Decreased stroke volume−brachial pulse pressure ratio in patients with type 2 diabetes over 50 years: the role of peripheral neuropathy.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2013
Same author

Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indices.

British journal of anaesthesia·2012

Arrhythmogenic right ventricular dysplasia (ARVD) is an underdiagnosed cardiomyopathy causing sudden death in young people. Diagnosis involves imaging and genetic factors, with treatments including medications and defibrillators.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Arrhythmogenic right ventricular dysplasia (ARVD) is an underrecognized cardiomyopathy.
  • It is a significant cause of sudden arrhythmic death in young individuals and can lead to heart failure.
  • ARVD presents a wide clinical spectrum, potentially linked to myocardial fat replacement and genetic predisposition to myocarditis.

Purpose of the Study:

  • To review the current understanding of arrhythmogenic right ventricular dysplasia (ARVD).
  • To discuss diagnostic criteria and methods for identifying ARVD.
  • To outline current and emerging treatment strategies for ARVD.

Main Methods:

  • Review of existing literature on arrhythmogenic right ventricular dysplasia (ARVD).
  • Discussion of diagnostic modalities including electrocardiography, echocardiography, nuclear medicine, MRI, and contrast ventriculography.

Related Experiment Videos

  • Analysis of etiological factors, clinical presentation, and therapeutic options.

    • Main Results:

    • ARVD is likely more frequent than commonly reported and presents diverse clinical manifestations.
    • Diagnostic tools like ECG, echocardiography, MRI, and ventriculography are crucial for identification.
    • The condition may stem from myocardial fatty infiltration and genetic susceptibility to environmental factors.

    Conclusions:

    • Accurate diagnosis of ARVD relies on a combination of imaging techniques and histological examination.
    • Management strategies encompass pharmacotherapy, ablative procedures, heart failure treatment, and potentially implantable defibrillators.
    • Further research into the genetic and environmental factors of ARVD is warranted.